[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:stk11-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"STK11 Gene",17,14,[8,16,23,29,35,42,48,55,61,67,73,79,85,91,97,104,111],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07017829","GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer",[12],"Phase 2","RECRUITING","2026-08-26T02:17:28.381459Z","2026-07-30T01:46:14.416741Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05098132","Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers",[20],"Phase 1\u002FPhase 2","2026-08-26T02:18:17.007929Z","2026-07-05T03:45:20.449302Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06495125","Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer",[12],"2026-08-26T02:19:25.538428Z","2026-05-05T02:43:28.885333Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07207395","A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.",[12],"2026-08-26T02:16:46.147215Z","2026-05-05T02:43:27.423330Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT05039801","IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors",[39],"Phase 1","2026-08-26T02:18:49.989941Z","2026-04-29T02:57:57.070174Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06195306","Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction",[12],"2026-08-26T02:18:31.164304Z","2026-05-05T02:43:26.724920Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":53,"content_modified":54},"NCT06122896","Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals",[52],"Early Phase 1","2026-08-26T02:17:13.277148Z","2026-05-05T02:43:27.075591Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT03729115","A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer",[],"2026-08-26T02:18:11.042248Z","2026-05-05T02:43:26.901351Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT07612046","A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening",[],"2026-08-26T02:16:27.227548Z","2026-07-19T19:36:05.076756Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT07038785","Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs",[],"2026-08-26T02:18:38.865010Z","2026-05-13T02:55:06.608906Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT06271291","Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts",[],"2026-08-26T02:18:36.226508Z","2026-05-13T02:55:06.430707Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT05006131","Pancreatic Cancer Screening for At-risk Individuals",[],"2026-08-26T02:17:12.307088Z","2026-05-13T02:55:06.277680Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT04970056","Pancreatic Cancer Early Detection Consortium",[],"2026-08-26T02:15:04.877798Z","2026-05-13T02:55:06.276618Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT02775461","Pancreas Registry and High Risk Registry",[],"2026-08-26T02:15:27.567165Z","2026-05-13T02:55:06.101947Z",{"nct_id":98,"title":99,"phases":100,"status":101,"updated_at":102,"content_modified":103},"NCT07690852","Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care",[],"NOT_YET_RECRUITING","2026-08-26T02:16:24.970704Z","2026-07-19T19:36:05.153122Z",{"nct_id":105,"title":106,"phases":107,"status":108,"updated_at":109,"content_modified":110},"NCT07358208","Prospective Familial Registry for Pancreas Research",[],"ENROLLING_BY_INVITATION","2026-08-26T02:19:26.493949Z","2026-06-16T05:54:07.881076Z",{"nct_id":112,"title":113,"phases":114,"status":115,"updated_at":116,"content_modified":117},"NCT05887492","Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T02:29:00.977561Z","2026-05-05T02:43:29.539927Z"]